Crystalvue Medical Corporation (TPEX:6527)
Taiwan · Delayed Price · Currency is TWD 76.80
+0.50 (0.66%)
Jan 22, 2026, 1:18 PM CST
Crystalvue Medical Market Cap
Crystalvue Medical has a market cap or net worth of 1.93 billion as of January 21, 2026. Its market cap has decreased by -11.18% in one year.
Market Cap
1.93B
Enterprise Value
1.84B
Revenue
905.73M
Ranking
n/a
PE Ratio
14.11
Stock Price
76.80
Market Cap Chart
Since April 29, 2015, Crystalvue Medical's market cap has increased from 1.04B to 1.93B, an increase of 86.32%. That is a compound annual growth rate of 5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.93B | 0.26% |
| Dec 31, 2025 | 1.93B | -10.37% |
| Dec 30, 2024 | 2.15B | -1.77% |
| Dec 29, 2023 | 2.19B | 76.51% |
| Dec 30, 2022 | 1.24B | 8.45% |
| Dec 30, 2021 | 1.14B | -3.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.73B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 31.09B |